Islet Sciences Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider : Reuters Investment Profile
Provider : Edison Investment Research
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Islet Sciences, Inc to acquire BHV Pharma
Islet Sciences, Inc:Signed a binding letter of intent to acquire Brighthaven Ventures, LLC d/b/a BHV Pharma.Says In exchange for 100 pct ownership of BHV, Islet Sciences will issue 30 million shares of Islet Sciences common stock to holders of BHV units.
Latest Developments forIslet Sciences Inc
- Islet Sciences and BHV Pharma enter into merger agreement; combined company to be named Avogenx, Inc
- Islet Sciences Inc announces positive 12-Week phase 2 clinical results for SGLT2 Inhibitor Remogliflozin Etabonate
- Islet Sciences announces unregistered sale of equity securities - Form 8-K
- Islet Sciences Inc Announces Appointment Of Chief Executive Officer-Form 8-K
Latest Key Developments inBiotechnology
- Flexion Therapeutics granted fast track status by the FDA for FX006
- Neurovive Pharmaceutical says Jan Nilsson new interim CEO
- XBiotech Inc announces phase 1/2 clinical study of novel true human therapeutic antibody
- Trevena announces positive results from phase 2b study of TRV130 in Acute Postoperative Pain
- Share this
- Digg this